Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Sucampo completes a new phase III clinical trial with SPI-0211 in constipation

Jan. 20, 2004

Significant improvements induced by renzapride in IBS

Jan. 19, 2004

Axcan submits sNDA for 1g mesalamine suppository

Jan. 19, 2004

Phase II trial design agreed for InKine's new generation purgative product

Jan. 19, 2004

Eisai assumes distribution responsibilities for Aciphex

Jan. 19, 2004

Nexium i.v. completes European MRP

Jan. 16, 2004

Actilon enters phase I for chronic HCV

Jan. 16, 2004

Novel NK1 antagonists in early development at Kyorin

Jan. 16, 2004

Second pivotal trial of methylnaltrexone for opioid-induced constipation

Jan. 15, 2004

New phase I trial for Traficet-EN

Jan. 15, 2004

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...